Improved oral delivery of N-(4 -hydroxyphenyl )retinamide with a novel LYM-X-SORB organized lipid complexMAURER, Barry J; KALOUS, Ondrej; BURGESS, Stephen W et al.Clinical cancer research. 2007, Vol 13, Num 10, pp 3079-3086, issn 1078-0432, 8 p.Article

Evaluation of a mucoadhesive fenretinide patch for local intraoral delivery: a strategy to reintroduce fenretinide for oral cancer chemopreventionHOLPUCH, Andrew S; PHELPS, Maynard P; BORDER, Michael B et al.Carcinogenesis (New York. Print). 2012, Vol 33, Num 5, pp 1098-1105, issn 0143-3334, 8 p.Article

Identification of mammalian target of rapamycin as a direct target of fenretinide both in vitro and in vivoHUA XIE; FENG ZHU; REDDY, Kanamata et al.Carcinogenesis (New York. Print). 2012, Vol 33, Num 9, pp 1814-1821, issn 0143-3334, 8 p.Article

Induction and intracellular localization of Nur77 dictate fenretinide-induced apoptosis of human liver cancer cellsHUI YANG; BUSHUE, Nathan; PENGLI BU et al.Biochemical pharmacology. 2010, Vol 79, Num 7, pp 948-954, issn 0006-2952, 7 p.Article

Relationship among pharmacokinetics and pharmacodynamics of fenretinide and plasma retinol reduction in neuroblastoma patientsFORMELLI, Franca; CAVADINI, Elena; LUKSCH, Roberto et al.Cancer chemotherapy and pharmacology. 2010, Vol 66, Num 5, pp 993-998, issn 0344-5704, 6 p.Article

Fenretinide-dependent upregulation of death receptors through ASK I and p38α enhances death receptor ligand-induced cell death in Ewing's sarcoma family of tumoursWHITE, D. E; BURCHILL, S. A.British journal of cancer. 2010, Vol 103, Num 9, pp 1380-1390, issn 0007-0920, 11 p.Article

The Combined Therapeutic Effects of Bortezomib and Fenretinide on Neuroblastoma Cells Involve Endoplasmic Reticulum Stress ResponsePAGNAN, Gabriella; DI PAOLO, Daniela; CILLI, Michele et al.Clinical cancer research (Print). 2009, Vol 15, Num 4, pp 1199-1209, issn 1078-0432, 11 p.Article

Block copolymer design for stable encapsulation of N -(4-hydroxyphenyl)retinamide into polymeric micelles in miceOKUDA, Tomoyuki; KAWAKAMI, Shigeru; YOKOYAMA, Masayuki et al.International journal of pharmaceutics. 2008, Vol 357, Num 1-2, pp 318-322, issn 0378-5173, 5 p.Article

Pharmacokinetics of oral fenretinide in neuroblastoma patients : indications for optimal dose and dosing schedule also with respect to the active metabolite 4-oxo-fenretinideFORMELLI, Franca; CAVADINI, Elena; LUKSCH, Roberto et al.Cancer chemotherapy and pharmacology. 2008, Vol 62, Num 4, pp 655-665, issn 0344-5704, 11 p.Article

The unhydrolyzable fenretinide analogue 4-hydroxybenzylretinone induces the proapoptotic genes GADD153 (CHOP) and Bcl-2-binding component 3 (PUMA) and apoptosis that is caspase-dependent and independent of the retinoic acid receptorANDING, Allyson L; CHAPMAN, Jason S; BARRETT, Derek W et al.Cancer research (Baltimore). 2007, Vol 67, Num 13, pp 6270-6277, issn 0008-5472, 8 p.Article

Hypoxia-mediated fenretinide (4-HPR) resistance in childhood acute lymphoblastic leukemia cellsBO YANG; LINGLING FAN; LIANG FANG et al.Cancer chemotherapy and pharmacology. 2006, Vol 58, Num 4, pp 540-546, issn 0344-5704, 7 p.Article

Inhibition of IL-8 release from CFTR-deficient lung epithelial cells following pre-treatment with fenretinideVILELA, Regina Mafia; LANDS, Larry C; MEEHAN, Brian et al.International immunopharmacology. 2006, Vol 6, Num 11, pp 1651-1664, issn 1567-5769, 14 p.Article

Amphiphilic poly(vinyl alcohol) derivatives as complexing agents for fenretinideORIENTI, I; ZUCCARI, G; BERGAMANTE, V et al.Biomacromolecules. 2006, Vol 7, Num 11, pp 3157-3163, issn 1525-7797, 7 p.Article

Chemopreventive N-(4-hydroxyphenyl)retinamide (fenretinide) targets deregulated Nf-κB and Mat1A genes in the early stages of rat liver carcinogenesisM.SIMILE, Maria; PAGNAN, Gabriella; FEO, Francesco et al.Carcinogenesis (New York. Print). 2005, Vol 26, Num 2, pp 417-427, issn 0143-3334, 11 p.Article

Cyclooxygenase-2 protein reduces tamoxifen and N-(4-hydroxyphenyl)retinamide inhibitory effects in breast cancer cellsTARI, Ana M; SIMEONE, Ann-Marie; LI, Yu-Jiang et al.Laboratory investigation. 2005, Vol 85, Num 11, pp 1357-1367, issn 0023-6837, 11 p.Article

Fenretinide cytotoxicity for Ewing's sarcoma and primitive neuroectodermal tumor cell lines is decreased by hypoxia and synergistically enhanced by ceramide modulatorsBATRA, Sandeep; REYNOLDS, C. Patrick; MAURER, Barry J et al.Cancer research (Baltimore). 2004, Vol 64, Num 15, pp 5415-5424, issn 0008-5472, 10 p.Article

Potent effect of 5-HPBR, a butanoate derivative of 4-HPR, on cell growth and apoptosis in cancer cellsHAN, Hye-Sook; KWON, Your-Ja; PARK, Si-Ho et al.International journal of cancer. 2004, Vol 109, Num 1, pp 58-64, issn 0020-7136, 7 p.Article

In vitro and in vivo antitumor activity of liposomal fenretinide targeted to human neuroblastomaRAFFAGHELLO, Lizzia; PAGNAN, Gabriella; PONZONI, Mirco et al.International journal of cancer. 2003, Vol 104, Num 5, pp 559-567, issn 0020-7136, 9 p.Article

Bak: A downstream mediator of fenretinide-induced apoptosis of SH-SY5Y neuroblastoma cellsLOVAT, Penny E; OLIVERIO, Serafina; CORAZZARI, Marco et al.Cancer research (Baltimore). 2003, Vol 63, Num 21, pp 7310-7313, issn 0008-5472, 4 p.Article

HER2/neu reduces the apoptotic effects of N-(4-hydroxyphenyl)retinamide (4-HPR) in breast cancer cells by decreasing nitric oxide productionSIMEONE, Ann-Marie; BROEMELING, Lyle David; ROSENBLUM, Josh et al.Oncogene (Basingstoke). 2003, Vol 22, Num 43, pp 6739-6747, issn 0950-9232, 9 p.Article

Relationships between plasma insulin-like growth factor-I and insulin-like growth factor binding protein-3 and second breast cancer risk in a prevention trial of FenretinideDECENSI, Andrea; VERONESI, Umberto; PERLOFF, Marjorie et al.Clinical cancer research. 2003, Vol 9, Num 13, pp 4722-4729, issn 1078-0432, 8 p.Article

Pharmacokinetics of all-trans retinoic acid, 13-cis retinoic acid, and fenretinide in plasma and brain of ratLE DOZE, F; DEBRUYNE, D; ALBESSARD, F et al.Drug metabolism and disposition. 2000, Vol 28, Num 2, pp 205-208, issn 0090-9556Article

New agents for acute myelogenous leukemiaZWIEBEL, J. A.Leukemia. 2000, Vol 14, Num 3, pp 488-490, issn 0887-6924Article

Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancerVERONESI, U; DE PALO, G; MURACA, M. G et al.Journal of the National Cancer Institute. 1999, Vol 91, Num 21, pp 1847-1856, issn 0027-8874Article

Tamoxifen and fenretinide in women with metastatic breast cancerZUJEWSKI, J; PAI, L; GOSSARD, M et al.Breast cancer research and treatment. 1999, Vol 57, Num 3, pp 277-283, issn 0167-6806Article